The deubiquitinating enzyme UCHL1 is a favorable prognostic marker in neuroblastoma as it promotes neuronal differentiation

Overview of attention for article published in Journal of Experimental & Clinical Cancer Research, October 2018

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 1 X user

googleplus: 1 Google+ user

Citations

dimensions_citation: 31 Dimensions

Readers on

mendeley: 34 Mendeley

Summary X Google+ Dimensions citations

So far, Dimensions has found 31 publications that cite this research output.

31

The most recent citing publications are shown below. View all 31 publications that cite this research output on Dimensions.

Identification of MYCN non-amplified neuroblastoma subgroups points towards molecular signatures for precision prognosis and therapy stratification

Article in British Journal of Cancer (March 2024)

Narrative review: precision medicine applications in neuroblastoma—current status and future prospects

Article in Translational Pediatrics (January 2024)

UBE4B interacts with the ITCH E3 ubiquitin ligase to induce Ku70 and c-FLIPL polyubiquitination and enhanced neuroblastoma apoptosis

Article in Cell Death & Disease (November 2023)

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.